Cargando…
PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform
Pancreatic and duodenal homeobox-1 (PDX-1) is a transcription factor that regulates insulin expression and islet maintenance in the adult pancreas. Our recent studies demonstrate that PDX-1 is an oncogene for pancreatic cancer and is overexpressed in pancreatic cancer. The purpose of this study was...
Autores principales: | Liu, Shi-He, Rao, Donald D., Nemunaitis, John, Senzer, Neil, Zhou, Guisheng, Dawson, David, Gingras, Marie-Claude, Wang, Zhaohui, Gibbs, Richard, Norman, Michael, Templeton, Nancy S., DeMayo, Francesco J., O'Malley, Bert, Sanchez, Robbi, Fisher, William E., Brunicardi, F. Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414490/ https://www.ncbi.nlm.nih.gov/pubmed/22905092 http://dx.doi.org/10.1371/journal.pone.0040452 |
Ejemplares similares
-
Notch1 Activation Up-Regulates Pancreatic and Duodenal Homeobox-1
por: Liu, Shi-He, et al.
Publicado: (2013) -
Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease
por: Simmons, Olivia, et al.
Publicado: (2012) -
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
por: Rao, Donald D., et al.
Publicado: (2018) -
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin
por: Zhou, Guisheng, et al.
Publicado: (2014) -
Safety and in vivo Expression of a GNE-Transgene: A Novel Treatment Approach for Hereditary Inclusion Body Myopathy-2
por: Phadke, Anagha P., et al.
Publicado: (2009)